Shinichiro Suzuki

8PUBLICATIONS
58CO-AUTHORS
Predictive and prognostic markersMolecular targetsHaematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Aug 25, 2026
Chromosome 1q Gain Defines a Plasma Cell-Dominant Adverse-Risk Subtype in AL Amyloidosis With Inferior Long-Term Survival.

|Mar 11, 2026
Constitutive EGFR Activation Induced by PTPRR Downregulation Confers Resistance to KRAS Inhibitors.

Hiroaki Kanemura, Toshiyuki Takehara, Osamu Maenishi

|Nov 13, 2025
Zongertinib, a Novel HER2 Tyrosine Kinase Inhibitor, Maintains an Anticancer Activity for Trastuzumab Deruxtecan-Resistant Cancers Harboring HER2-Overexpression.

Takashi Kurosaki, Shinichiro Suzuki, Kimio Yonesaka

|Jan 22, 2025
Immune evasion through mitochondrial transfer in the tumour microenvironment.

Hideki Ikeda, Katsushige Kawase, Tatsuya Nishi

|Dec 31, 2024
Proteolysis targeting chimera (PROTAC)-driven antibody internalization of oncogenic cell surface receptors.

Ezequiel J Tolosa, Lin Yang, Jennifer Ayers-Ringler

|Aug 08, 2021
KRAS Inhibitor Resistance in MET-Amplified KRAS G12C Non-Small Cell Lung Cancer Induced By RAS- and Non-RAS-Mediated Cell Signaling Mechanisms.

Shinichiro Suzuki, Kimio Yonesaka, Takeshi Teramura

Pageof 2

Frequent Collaborators

6 joint publications

Hidetoshi Hayashi

3 joint publications

Yasutoshi Tatsumi

3 joint publications

Hideki Makinoshima

3 joint publications

Sho Aki